Gonal-F (Follitropin alfa)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Multifollicular Stimulation
Conditions
Multifollicular Stimulation
Trial Timeline
Apr 1, 2009 → Mar 1, 2010
NCT ID
NCT01075854About Gonal-F (Follitropin alfa)
Gonal-F (Follitropin alfa) is a pre-clinical stage product being developed by Merck for Multifollicular Stimulation. The current trial status is completed. This product is registered under clinical trial identifier NCT01075854. Target conditions include Multifollicular Stimulation.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01075854 | Pre-clinical | Completed |
Competing Products
1 competing product in Multifollicular Stimulation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Recombinant-follicle stimulating hormone (r-FSH) | Merck | Pre-clinical | 23 |